Medicure Inc.
TSXV: MPH.V0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange Ventures
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Albert David Friesen
- Employees
- 25
- Headquarters
- Winnipeg, Canada
- IPO year
- 2012
- Market cap
- CA$12.3M
- Website
- https://www.medicure.com
Loading MPH…
Loading profile data…Frequently asked questions about MPH
What does Medicure Inc. (MPH.V) do?
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including u...
Where does MPH.V trade?
Medicure Inc. (MPH.V) trades on the Toronto Stock Exchange Ventures.
What sector is MPH.V in?
Medicure Inc. (MPH.V) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Medicure Inc.?
Albert David Friesen is the chief executive officer of Medicure Inc. (MPH.V).
Where is Medicure Inc. headquartered?
Medicure Inc. is headquartered in Canada.
Does MPH.V pay a dividend?
Medicure Inc. (MPH.V) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MPH.V go public?
Medicure Inc. (MPH.V) completed its initial public offering in 2012.